Abstract
From 1974 to 1979, 138 patients who were treated for endometrial carcinoma underwent pelvic and paraaortic node dissection. Eighteen patients had positive paraaortic nodes (12.5%). Eleven out of twelve patients with microscopic disease and five out of six patients with gross disease received 5000 XRT to the paraaortic region as well as 4500 XRT to the pelvis. Megace at a dose of 160 mg daily was also given. Five-year survival rates were as follows: 66.7% (8/12) for microscopic disease, 16.7% (1/6) for gross disease. For Stage I microscopic disease, 66.5% (5/8), for Stage I gross disease 0% (0/4). For Stage II microscopic disease 66.7% (2/3) and for Stage II gross disease 50% (1/2). External RT to the paraaortic nodes appears to be beneficial for patients with microscopic disease in Stage I and Stage II endometrial carcinoma with minimal complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
